Pasithea Stock Plunges 14.14% Amid CEO Share Sale
Generated by AI AgentAinvest Movers Radar
Thursday, May 15, 2025 7:34 am ET1min read
KTTA--
On May 15, 2025, Pasithea's stock price plummeted by 14.14% during pre-market trading, sparking concerns among investors about the company's recent developments.
Pasithea Therapeutics' CEO, Tiago Marques, recently sold shares worth $792, which has raised eyebrows among market observers. This transaction has added to the uncertainty surrounding the company's future prospects, potentially contributing to the significant drop in its stock price.

Knowing stock market today at a glance
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet